{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:09:47Z","timestamp":1791896987889,"version":"4.3.4"},"reference-count":272,"publisher":"Bioscientifica","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age. Besides hyperandrogenism, oligomenorrhea and fertility issues, it is associated with a high prevalence of metabolic disorders and cardiovascular risk factors. Several genetic polymorphisms have been identified for possible associations with cardiometabolic derangements in PCOS. Different PCOS phenotypes differ significantly in their cardiometabolic risk, which worsens with severity of androgen excess. Due to methodological difficulties, longer time-scale data about cardiovascular morbidity and mortality in PCOS and about possible beneficial effects of different treatment interventions is missing leaving many issues regarding cardiovascular risk unresolved.<\/jats:p>","DOI":"10.1530\/ec-18-0129","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T09:25:21Z","timestamp":1527585921000},"page":"R238-R251","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":57,"title":["Cardiometabolic risk in polycystic ovary syndrome"],"prefix":"10.1530","volume":"7","author":[{"given":"Katica","family":"Bajuk Studen","sequence":"first","affiliation":[{"name":"1Nuclear Medicine Department, University Medical Centre Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Pfeifer","sequence":"additional","affiliation":[{"name":"2Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref2601","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"ref2011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2441","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6939-14-6","article-title":"Media, politics and science policy: MS and evidence from the CCSVI Trenches","volume":"14","year":"2013","journal-title":"BMC Medical Ethics"},{"key":"ref1461","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/hmbci-2013-0014","article-title":"The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome","volume":"15","year":"2013","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"key":"ref2051","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"ref2061","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","year":"2006","journal-title":"BJOG"},{"key":"ref2241","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/humupd\/dmr046","article-title":"Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","year":"2012","journal-title":"Human Reproduction Update"},{"key":"ref2541","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-13-0617","article-title":"The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review","volume":"169","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1249\/MSS.0b013e31829ba9a1","article-title":"Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness","volume":"45","year":"2013","journal-title":"Medicine and Science in Sports and Exercise"},{"key":"ref2031","first-page":"2044","article-title":"Long-term testosterone administration increases visceral fat in female to male transsexuals","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/jog.12985","article-title":"Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype","volume":"42","year":"2016","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","year":"2003","journal-title":"Human Reproduction"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1210\/jc.2010-0868","article-title":"Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity \u2013 but not a PCOS-associated phenomenon","volume":"95","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref501","first-page":"340","article-title":"Is cardiovascular risk in women with PCOS a real risk? Current insights","volume":"42","year":"2017","journal-title":"Minerva Endocrinologica"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrendo.2014.29","article-title":"Insulin resistance and hyperglycaemia in cardiovascular disease development","volume":"10","year":"2014","journal-title":"Nature Reviews Endocrinology"},{"key":"ref2101","doi-asserted-by":"crossref","first-page":"e2953","DOI":"10.1371\/journal.pone.0002953","article-title":"The CAPN10 gene is associated with insulin resistance phenotypes in the spanish population","volume":"3","year":"2008","journal-title":"PLoS ONE"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/1947-2714.161246","article-title":"Anti-inflammatory dietary combo in overweight and obese women with polycystic ovary syndrome","volume":"7","year":"2015","journal-title":"North American Journal of Medicine and Science"},{"key":"ref1911","doi-asserted-by":"crossref","first-page":"e0151960","DOI":"10.1371\/journal.pone.0151960","article-title":"Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase","volume":"11","year":"2016","journal-title":"PLoS ONE"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","article-title":"Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up","volume":"6","year":"2006","journal-title":"Current Diabates Reports"},{"key":"ref2571","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/humrep\/des138","article-title":"The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome","volume":"27","year":"2012","journal-title":"Human Reproduction"},{"key":"ref1641","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/09513590903015528","article-title":"Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome","volume":"25","year":"2009","journal-title":"Gynecological Endocrinology"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"e0151960","DOI":"10.1371\/journal.pone.0151960","article-title":"Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: role of myeloperoxidase","volume":"11","year":"2016","journal-title":"PLoS ONE"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/humrep\/den211","article-title":"Obesity, body composition and metabolic disturbances in polycystic ovary syndrome","volume":"23","year":"2008","journal-title":"Human Reproduction"},{"key":"ref2511","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.2012.04434.x","article-title":"Vitamin D in the aetiology and management of polycystic ovary syndrome","volume":"77","year":"2012","journal-title":"Clinical Endocrinology"},{"key":"ref2271","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1358863X16682107","article-title":"Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers","volume":"22","year":"2017","journal-title":"Vascular Medicine"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","year":"2016","journal-title":"Nature Reviews Disease Primer"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","year":"2015","journal-title":"European Journal of Endocrinology"},{"key":"ref2041","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/gye.16.1.45.51","article-title":"Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome","volume":"16","year":"2002","journal-title":"Gynecological Endocrinology"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome \u2013 a hypothesis","volume":"174","year":"2002","journal-title":"Journal of Endocrinology"},{"key":"ref1571","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref181","first-page":"48","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"9","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1821","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1152\/japplphysiol.00695.2005","article-title":"Disorders of glucose metabolism in sleep apnea","volume":"99","year":"2005","journal-title":"Journal of Applied Physiology"},{"key":"ref1951","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1530\/EJE-15-0567","article-title":"Increased prevalence of polycystic ovary syndrome in premenopausal women with nonalcoholic fatty liver disease","volume":"173","year":"2015","journal-title":"European Journal of Endocrinology"},{"key":"ref2461","first-page":"119","article-title":"ADHD medication use following FDA risk warnings","volume":"15","year":"2012","journal-title":"Journal of Mental Health Policy and Economics"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/jc.2010-1187","article-title":"Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome","volume":"96","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.0000157697.54255.CE","article-title":"Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN)","volume":"111","year":"2005","journal-title":"Circulation"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1961","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0004-28032015000200008","article-title":"Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome","volume":"52","year":"2015","journal-title":"Arquivos de Gastroenterologia"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.beem.2015.06.005","article-title":"The biomarker sex hormone-binding globulin \u2013 from established applications to emerging trends in clinical medicine","volume":"29","year":"2015","journal-title":"Best Practice and Research: Clinical Endocrinology and Metabolism"},{"key":"ref2171","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","year":"2001","journal-title":"Circulation"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","article-title":"Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?","volume":"64","year":"2015","journal-title":"Metabolism"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.beem.2015.06.005","article-title":"The biomarker sex hormone-binding globulin \u2013 from established applications to emerging trends in clinical medicine","volume":"29","year":"2015","journal-title":"Best Practice and Research: Clinical Endocrinology and Metabolism"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-142-3-200502010-00010","article-title":"Obstructive sleep apnea","volume":"142","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"ref2611","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-13-0617","article-title":"The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review","volume":"169","year":"2013","journal-title":"European Journal of Endocrinology"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"166","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/2230-8210.131186","article-title":"Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India","volume":"18","year":"2014","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"ref2151","first-page":"246","article-title":"Is there association between the development of metabolic syndrome in polycystic ovary syndrome patients with the C677T metylenetetrahydrofolate reuctace gene polymorphism?","volume":"87","year":"2016","journal-title":"Polish Gynaecology"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"ref1901","first-page":"536","article-title":"Elevated thrombin activatable fibrinolysis inhibitor levels in women with polycystic ovary syndrome","volume":"31","year":"2015","journal-title":"Gynecological Endocrinology"},{"key":"ref2131","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1744-313X.2009.00867.x","article-title":"The relationship of the interleukin-6 \u2212174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients","volume":"36","year":"2009","journal-title":"International Journal of Immunogenetics"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1891","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/09513590.2013.819086","article-title":"Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G\/5G polymorphism and metabolic\/proinflammatory factors in polycystic ovary syndrome","volume":"29","year":"2013","journal-title":"Gynecological Endocrinology"},{"key":"ref2431","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10815-008-9280-8","article-title":"Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey","volume":"26","year":"2009","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/EC-17-0129","article-title":"Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature","volume":"6","year":"2017","journal-title":"Endocrine Connections"},{"key":"ref2641","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/03007995.2017.1279597","article-title":"Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials","volume":"33","year":"2017","journal-title":"Current Medical Research and Opinion"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2017.08.011","article-title":"Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome","volume":"217","year":"2017","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.3390\/nu7064555","article-title":"Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"7","year":"2015","journal-title":"Nutrients"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/AC.71.3.3152087","article-title":"CPAP therapy reduces blood pressure for patients with obstructive sleep apnoea: an update meta-analysis of randomized clinical trials","volume":"71","year":"2016","journal-title":"Acta Cardiologica"},{"key":"ref2181","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in young women with polycystic ovary syndrome","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1991","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","year":"2011","journal-title":"Human Reproduction Update"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1080\/03007995.2017.1279597","article-title":"Effect of metformin on clinical, metabolic and endocrine outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials","volume":"33","year":"2017","journal-title":"Current Medical Research and Opinion"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"ref1511","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-13-1007","article-title":"Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome","volume":"171","year":"2014","journal-title":"European Journal of Endocrinology"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12944-017-0448-z","article-title":"Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome","volume":"16","year":"2017","journal-title":"Lipids in Health and Disease"},{"key":"ref2161","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.steroids.2011.12.005","article-title":"Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS)","volume":"77","year":"2012","journal-title":"Steroids"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Polycystic ovary syndrome","volume":"375","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","year":"2010","journal-title":"Human Reproduction Update"},{"key":"ref2361","doi-asserted-by":"publisher","first-page":"201196","DOI":"10.1210\/jc.2010-1709","article-title":"DomingoKCohnBACedarsMI Menstrual irregularity cardiovascular mortality of and https org","journal-title":"Journal Clinical Endocrinology Metabolism"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/AC.71.3.3152087","article-title":"CPAP therapy reduces blood pressure for patients with obstructive sleep apnoea: an update meta-analysis of randomized clinical trials","volume":"71","year":"2016","journal-title":"Acta Cardiologica"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome","volume":"22","year":"2007","journal-title":"Human Reproduction"},{"key":"ref1281","doi-asserted-by":"publisher","first-page":"201398","DOI":"10.1210\/jc.2013-1041","article-title":"Oral contraception vs insulin sensitization for months in nonobese adolescents with androgen excess : posttreatment differences in reactive protein intima - media thickness visceral adiposity insulin sensitivity and menstrual regularity of and https org","author":"BermejoAde ZegherF","journal-title":"Journal Clinical Endocrinology Metabolism"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1210\/jc.2017-01739","article-title":"The efficacy of 24-month metformin for improving menses, hormones, and metabolic profiles in polycystic ovary syndrome","volume":"103","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1441","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","year":"1992","journal-title":"Diabetes"},{"key":"ref1971","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s12170-012-0275-8","article-title":"Impact of broadened coverage of smoking cessation treatments on cardiovascular disease","volume":"6","year":"2012","journal-title":"Current Cardiovascular Risk Reports"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1210\/jc.2005-0151","article-title":"Predictors of endothelial dysfunction in young women with polycystic ovary syndrome","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","year":"2009","journal-title":"Fertility and Sterility"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","year":"2001","journal-title":"American Journal of Medicine"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S0004-28032015000200008","article-title":"Prevalence of non-alcoholic fatty liver disease in women with polycystic ovary syndrome and its correlation with metabolic syndrome","volume":"52","year":"2015","journal-title":"Arquivos de Gastroenterologia"},{"key":"ref2001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/hmbci-2013-0014","article-title":"The impact of hyperandrogenism in female obesity and cardiometabolic diseases associated with polycystic ovary syndrome","volume":"15","year":"2013","journal-title":"Hormone Molecular Biology and Clinical Investigation"},{"key":"ref1451","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","year":"2016","journal-title":"Nature Reviews Disease Primer"},{"key":"ref2231","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2265.2012.04490.x","article-title":"Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies","volume":"78","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/resp.12573","article-title":"Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: a systematic review and meta-analysis","volume":"20","year":"2015","journal-title":"Respirology"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4187\/respcare.03739","article-title":"Effect of CPAP on endothelial function in subjects with obstructive sleep apnea: a meta-analysis","volume":"60","year":"2015","journal-title":"Respiratory Care"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","year":"2001","journal-title":"Human Reproduction"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","year":"2012","journal-title":"Fertility and Sterility"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6939-14-6","article-title":"Media, politics and science policy: MS and evidence from the CCSVI Trenches","volume":"14","year":"2013","journal-title":"BMC Medical Ethics"},{"key":"ref1721","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","year":"2013","journal-title":"Obesity Reviews"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-13-1007","article-title":"Diverse impacts of aging on insulin resistance in lean and obese women with polycystic ovary syndrome: evidence from 1345 women with the syndrome","volume":"171","year":"2014","journal-title":"European Journal of Endocrinology"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.06.00107805","article-title":"Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up","volume":"28","year":"2006","journal-title":"European Respiratory Journal"},{"key":"ref2741","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4239\/wjd.v3.i4.71","article-title":"Defining the role of bariatric surgery in polycystic ovarian syndrome patients","volume":"3","year":"2012","journal-title":"World Journal of Diabetes"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1471-0528.2006.01008.x","article-title":"PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors","volume":"113","year":"2006","journal-title":"BJOG"},{"key":"ref1801","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"ref1681","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","year":"1990","journal-title":"Clinical Endocrinology"},{"key":"ref2451","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s12170-012-0275-8","article-title":"Impact of broadened coverage of smoking cessation treatments on cardiovascular disease","volume":"6","year":"2012","journal-title":"Current Cardiovascular Risk Reports"},{"key":"ref1141","first-page":"28","article-title":"Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency","volume":"36","year":"2013","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref2281","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejogrb.2017.08.011","article-title":"Ultrasonographic evaluation of intra-abdominal fat distribution and study of its influence on subclinical atherosclerosis in women with polycystic ovarian syndrome","volume":"217","year":"2017","journal-title":"European Journal of Obstetrics, Gynecology and Reproductive Biology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2651","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humupd\/dmv063","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"22","year":"2016","journal-title":"Human Reproduction Update"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","year":"2015","journal-title":"Endocrine Reviews"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1561","first-page":"48","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"9","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2351","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","year":"2000","journal-title":"Human Fertility"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.2196\/jmir.5417","article-title":"\u2018Less than a wife\u2019: a study of polycystic ovary syndrome content in teen and women\u2019s digital magazines","volume":"18","year":"2016","journal-title":"Journal of Medical Internet Research"},{"key":"ref2291","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1210\/jc.2010-0868","article-title":"Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity \u2013 but not a PCOS-associated phenomenon","volume":"95","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2121","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12944-017-0448-z","article-title":"Effect of the R92H and A379V genotypes of platelet-activating factor acetylhydrolase on its enzyme activity, oxidative stress and metabolic profile in Chinese women with polycystic ovary syndrome","volume":"16","year":"2017","journal-title":"Lipids in Health and Disease"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","year":"2015","journal-title":"Hormones"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"E628","DOI":"10.1210\/jc.2012-3908","article-title":"Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2591","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17\u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/js.2017-00192","article-title":"Insulin resistance, hyperinsulinemia and mitochondria dysfunction in non-obese girls woth polycystic ovary syndrome","volume":"1","year":"2017","journal-title":"Journal of the Endocrine Society"},{"key":"ref2311","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","year":"2018","journal-title":"Cardiovascular Diabetology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/diab.41.10.1257","article-title":"Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome","volume":"41","year":"1992","journal-title":"Diabetes"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1161\/ATVBAHA.114.304136","article-title":"Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the coronary artery risk development in young adults women\u2019s study","volume":"34","year":"2014","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/NSS.S127475","article-title":"Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies","volume":"10","year":"2018","journal-title":"Nature and Science of Sleep"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07315724.2012.10720017","article-title":"Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study","volume":"31","year":"2012","journal-title":"Journal of the American College of Nutrition"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.0000157697.54255.CE","article-title":"Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN)","volume":"111","year":"2005","journal-title":"Circulation"},{"key":"ref2201","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1093\/humrep\/dem324","article-title":"Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome","volume":"22","year":"2007","journal-title":"Human Reproduction"},{"key":"ref1621","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrendo.2014.29","article-title":"Insulin resistance and hyperglycaemia in cardiovascular disease development","volume":"10","year":"2014","journal-title":"Nature Reviews Endocrinology"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humupd\/dmx012","article-title":"Prevalence of \u2018obesity-associated gonadal dysfunction\u2019 in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis","volume":"23","year":"2017","journal-title":"Human Reproduction Update"},{"key":"ref2701","doi-asserted-by":"crossref","first-page":"e0126119","DOI":"10.1371\/journal.pone.0126119","article-title":"Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome","volume":"10","year":"2015","journal-title":"PLoS ONE"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/eje.1.02058","article-title":"Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS","volume":"154","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref91","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/humrep\/16.9.1995","article-title":"Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome","volume":"16","year":"2001","journal-title":"Human Reproduction"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"ref41","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","year":"1992","journal-title":"Polycystic Ovary Syndrome"},{"key":"ref2411","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","year":"2012","journal-title":"Fertility and Sterility"},{"key":"ref2251","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1210\/en.2015-1159","article-title":"Hyperandrogenism and insulin resistance, not changes in body weight, mediate the development of endothelial dysfunction in a female rat model of polycystic ovary syndrome (PCOS)","volume":"156","year":"2015","journal-title":"Endocrinology"},{"key":"ref2721","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07435800.2017.1294602","article-title":"Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved \u03b2-cell function and insulin sensitivity in metformin treated PCOS","volume":"42","year":"2017","journal-title":"Endocrine Research"},{"key":"ref561","first-page":"e23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis","volume":"14","year":"2014","journal-title":"Hepatitis Monthly"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","year":"2011","journal-title":"Human Reproduction Update"},{"key":"ref2711","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13679-014-0127-6","article-title":"Aspects of cardiometabolic risk in women with polycystic ovary syndrome","volume":"3","year":"2014","journal-title":"Current Obesity Reports"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2013-2385","article-title":"Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2071","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","year":"2014","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/humrep\/den211","article-title":"Obesity, body composition and metabolic disturbances in polycystic ovary syndrome","volume":"23","year":"2008","journal-title":"Human Reproduction"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/1464727002000198781","article-title":"Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study","volume":"3","year":"2000","journal-title":"Human Fertility"},{"key":"ref991","first-page":"96351","article-title":"The prevalence of polycystic ovary syndrome in reproductive aged women of different ethnicity: a systematic review and meta-analysis","volume":"8","year":"2015","journal-title":"Oncotarget"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1744-313X.2009.00867.x","article-title":"The relationship of the interleukin-6 \u2212174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients","volume":"36","year":"2009","journal-title":"International Journal of Immunogenetics"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"e0126119","DOI":"10.1371\/journal.pone.0126119","article-title":"Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome","volume":"10","year":"2015","journal-title":"PLoS ONE"},{"key":"ref1691","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09513590.2011.589929","article-title":"Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance","volume":"28","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10815-008-9280-8","article-title":"Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey","volume":"26","year":"2009","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/07435800.2017.1294602","article-title":"Add on DPP-4 inhibitor alogliptin alone or in combination with pioglitazone improved \u03b2-cell function and insulin sensitivity in metformin treated PCOS","volume":"42","year":"2017","journal-title":"Endocrine Research"},{"key":"ref2081","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study","volume":"103","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2211","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref731","first-page":"3941","article-title":"Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome","volume":"11","year":"2014","journal-title":"Molecular Medicine Reports"},{"key":"ref771","first-page":"246","article-title":"Is there association between the development of metabolic syndrome in polycystic ovary syndrome patients with the C677T metylenetetrahydrofolate reuctace gene polymorphism?","volume":"87","year":"2016","journal-title":"Polish Gynaecology"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref981","doi-asserted-by":"publisher","first-page":"201196","DOI":"10.1210\/jc.2010-1709","article-title":"DomingoKCohnBACedarsMI Menstrual irregularity cardiovascular mortality of and https org","journal-title":"Journal Clinical Endocrinology Metabolism"},{"key":"ref1921","doi-asserted-by":"crossref","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","year":"2018","journal-title":"PLoS Medicine"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","year":"2010","journal-title":"Human Reproduction Update"},{"key":"ref651","first-page":"2044","article-title":"Long-term testosterone administration increases visceral fat in female to male transsexuals","volume":"82","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2221","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1210\/jc.2003-031867","article-title":"Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1421","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: towards a rational approach","year":"1992","journal-title":"Polycystic Ovary Syndrome"},{"key":"ref2671","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","year":"2015","journal-title":"Hormones"},{"key":"ref1041","first-page":"1","article-title":"ConwayGDewaillyDDiamanti KandarakisEEscobar The polycystic ovary syndrome : a position statement from the European of of https org","journal-title":"Society Endocrinology European Journal Endocrinology"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/09513590802234253","article-title":"Body fat composition and distribution in women with polycystic ovary syndrome","volume":"24","year":"2008","journal-title":"Gynecological Endocrinology"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1530\/EC-17-0129","article-title":"Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature","volume":"6","year":"2017","journal-title":"Endocrine Connections"},{"key":"ref931","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","year":"2018","journal-title":"Cardiovascular Diabetology"},{"key":"ref2091","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4103\/2230-8210.131186","article-title":"Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India","volume":"18","year":"2014","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1210\/jc.2004-1843","article-title":"Changes in glucose tolerance over time in women with polycystic ovary syndrome: a controlled study","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2301","first-page":"1","article-title":"Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure","volume":"2015","year":"2015","journal-title":"International Journal of Endocrinology"},{"key":"ref2341","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1210\/jcem.87.5.8471","article-title":"Menstrual cycle irregularity and risk for future cardiovascular disease","volume":"87","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","year":"1992","journal-title":"Clinical Endocrinology"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/humupd\/dmr025","article-title":"Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome","volume":"17","year":"2011","journal-title":"Human Reproduction Update"},{"key":"ref1241","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-10-0709","article-title":"Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome","volume":"164","year":"2011","journal-title":"European Journal of Endocrinology"},{"key":"ref2481","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.fertnstert.2008.09.018","article-title":"Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"92","year":"2009","journal-title":"Fertility and Sterility"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"166","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2531","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.3390\/nu7064555","article-title":"Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"7","year":"2015","journal-title":"Nutrients"},{"key":"ref2691","doi-asserted-by":"crossref","first-page":"e17178","DOI":"10.1371\/journal.pone.0017178","article-title":"Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy","volume":"6","year":"2011","journal-title":"PLoS ONE"},{"key":"ref1671","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.fertnstert.2008.09.003","article-title":"Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women","volume":"92","year":"2009","journal-title":"Fertility and Sterility"},{"key":"ref2421","first-page":"1","article-title":"ConwayGDewaillyDDiamanti KandarakisEEscobar The polycystic ovary syndrome : a position statement from the European of of https org","journal-title":"Society Endocrinology European Journal Endocrinology"},{"key":"ref2381","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: a 21-year controlled follow-up study","volume":"96","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.steroids.2011.12.005","article-title":"Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS)","volume":"77","year":"2012","journal-title":"Steroids"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"ref2321","doi-asserted-by":"crossref","first-page":"32","DOI":"10.7326\/0003-4819-126-1-199701010-00005","article-title":"Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization","volume":"126","year":"1997","journal-title":"Annals of Internal Medicine"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/jc.2008-0115","article-title":"Comparison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome","volume":"93","year":"2008","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref811","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","year":"2000","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"ref921","first-page":"1","article-title":"Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure","volume":"2015","year":"2015","journal-title":"International Journal of Endocrinology"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","year":"1992","journal-title":"Clinical Endocrinology"},{"key":"ref2331","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","year":"2003","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2501","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/1947-2714.161246","article-title":"Anti-inflammatory dietary combo in overweight and obese women with polycystic ovary syndrome","volume":"7","year":"2015","journal-title":"North American Journal of Medicine and Science"},{"key":"ref2561","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2013-2385","article-title":"Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09513590.2011.589929","article-title":"Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance","volume":"28","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"ref2661","doi-asserted-by":"publisher","first-page":"201398","DOI":"10.1210\/jc.2013-1041","article-title":"Oral contraception vs insulin sensitization for months in nonobese adolescents with androgen excess : posttreatment differences in reactive protein intima - media thickness visceral adiposity insulin sensitivity and menstrual regularity of and https org","author":"BermejoAde ZegherF","journal-title":"Journal Clinical Endocrinology Metabolism"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1152\/japplphysiol.00695.2005","article-title":"Disorders of glucose metabolism in sleep apnea","volume":"99","year":"2005","journal-title":"Journal of Applied Physiology"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2265.2008.03247.x","article-title":"Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)","volume":"69","year":"2008","journal-title":"Clinical Endocrinology"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humupd\/dmv063","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"22","year":"2016","journal-title":"Human Reproduction Update"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/humrep\/des138","article-title":"The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome","volume":"27","year":"2012","journal-title":"Human Reproduction"},{"key":"ref2371","first-page":"96351","article-title":"The prevalence of polycystic ovary syndrome in reproductive aged women of different ethnicity: a systematic review and meta-analysis","volume":"8","year":"2015","journal-title":"Oncotarget"},{"key":"ref2401","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","year":"2010","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2265.2012.04490.x","article-title":"Endothelial function measured using flow-mediated dilation in polycystic ovary syndrome: a meta-analysis of the observational studies","volume":"78","year":"2013","journal-title":"Clinical Endocrinology"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2391","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/humupd\/dmr001","article-title":"PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis","volume":"17","year":"2011","journal-title":"Human Reproduction Update"},{"key":"ref1741","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1210\/js.2017-00192","article-title":"Insulin resistance, hyperinsulinemia and mitochondria dysfunction in non-obese girls woth polycystic ovary syndrome","volume":"1","year":"2017","journal-title":"Journal of the Endocrine Society"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejim.2016.11.010","article-title":"Continuous positive airway pressure and diabetes risk in sleep apnea patients: a systemic review and meta-analysis","volume":"39","year":"2017","journal-title":"European Journal of Internal Medicine"},{"key":"ref1881","first-page":"340","article-title":"Is cardiovascular risk in women with PCOS a real risk? Current insights","volume":"42","year":"2017","journal-title":"Minerva Endocrinologica"},{"key":"ref1981","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","article-title":"Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?","volume":"64","year":"2015","journal-title":"Metabolism"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-142-3-200502010-00010","article-title":"Obstructive sleep apnea","volume":"142","year":"2005","journal-title":"Annals of Internal Medicine"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/gye.16.1.45.51","article-title":"Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome","volume":"16","year":"2002","journal-title":"Gynecological Endocrinology"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200005113421901","article-title":"Prospective study of the association between sleep-disordered breathing and hypertension","volume":"342","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/jog.12985","article-title":"Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype","volume":"42","year":"2016","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/09513590.2013.819086","article-title":"Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G\/5G polymorphism and metabolic\/proinflammatory factors in polycystic ovary syndrome","volume":"29","year":"2013","journal-title":"Gynecological Endocrinology"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.fertnstert.2008.09.003","article-title":"Clinical and biochemical presentations of polycystic ovary syndrome among obese and nonobese women","volume":"92","year":"2009","journal-title":"Fertility and Sterility"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","year":"2001","journal-title":"Circulation"},{"key":"ref1941","first-page":"e23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis","volume":"14","year":"2014","journal-title":"Hepatitis Monthly"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1183\/09031936.06.00107805","article-title":"Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up","volume":"28","year":"2006","journal-title":"European Respiratory Journal"},{"key":"ref1831","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1210\/jc.2010-1187","article-title":"Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome","volume":"96","year":"2011","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"749","DOI":"10.4187\/respcare.03739","article-title":"Effect of CPAP on endothelial function in subjects with obstructive sleep apnea: a meta-analysis","volume":"60","year":"2015","journal-title":"Respiratory Care"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"18","year":"2003","journal-title":"Human Reproduction"},{"key":"ref1301","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1755-5922.2010.00256.x","article-title":"OkersonTChiltonRJ The cardiovascular effects of receptor agonists https org","journal-title":"Cardiovascular Therapeutics"},{"key":"ref2631","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1210\/jc.2017-01739","article-title":"The efficacy of 24-month metformin for improving menses, hormones, and metabolic profiles in polycystic ovary syndrome","volume":"103","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1471","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"e17178","DOI":"10.1371\/journal.pone.0017178","article-title":"Exenatide improves glucose homeostasis and prolongs survival in a murine model of dilated cardiomyopathy","volume":"6","year":"2011","journal-title":"PLoS ONE"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"E628","DOI":"10.1210\/jc.2012-3908","article-title":"Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome","volume":"98","year":"2013","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejim.2016.11.010","article-title":"Continuous positive airway pressure and diabetes risk in sleep apnea patients: a systemic review and meta-analysis","volume":"39","year":"2017","journal-title":"European Journal of Internal Medicine"},{"key":"ref521","first-page":"536","article-title":"Elevated thrombin activatable fibrinolysis inhibitor levels in women with polycystic ovary syndrome","volume":"31","year":"2015","journal-title":"Gynecological Endocrinology"},{"key":"ref2491","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/07315724.2012.10720017","article-title":"Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovary syndrome: a randomized controlled intervention study","volume":"31","year":"2012","journal-title":"Journal of the American College of Nutrition"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/09513590802234253","article-title":"Body fat composition and distribution in women with polycystic ovary syndrome","volume":"24","year":"2008","journal-title":"Gynecological Endocrinology"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1210\/en.2015-1159","article-title":"Hyperandrogenism and insulin resistance, not changes in body weight, mediate the development of endothelial dysfunction in a female rat model of polycystic ovary syndrome (PCOS)","volume":"156","year":"2015","journal-title":"Endocrinology"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/resp.12573","article-title":"Effect of CPAP therapy on endothelial function in obstructive sleep apnoea: a systematic review and meta-analysis","volume":"20","year":"2015","journal-title":"Respirology"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4239\/wjd.v3.i4.71","article-title":"Defining the role of bariatric surgery in polycystic ovarian syndrome patients","volume":"3","year":"2012","journal-title":"World Journal of Diabetes"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1210\/jcem.86.10.7904","article-title":"Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy","volume":"86","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","article-title":"Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a United Kingdom primary care database","volume":"15","year":"2018","journal-title":"PLoS Medicine"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/NSS.S127475","article-title":"Sleep disturbances in women with polycystic ovary syndrome: prevalence, pathophysiology, impact and management strategies","volume":"10","year":"2018","journal-title":"Nature and Science of Sleep"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2007.02764.x","article-title":"Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome","volume":"66","year":"2007","journal-title":"Clinical Endocrinology"},{"key":"ref2751","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/humupd\/dmx012","article-title":"Prevalence of \u2018obesity-associated gonadal dysfunction\u2019 in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis","volume":"23","year":"2017","journal-title":"Human Reproduction Update"},{"key":"ref2681","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1755-5922.2010.00256.x","article-title":"OkersonTChiltonRJ The cardiovascular effects of receptor agonists https org","journal-title":"Cardiovascular Therapeutics"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","year":"2001","journal-title":"American Journal of Medicine"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref1581","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","year":"2005","journal-title":"Obstetrics and Gynecology"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17\u03b1 activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1530\/eje.1.02058","article-title":"Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS","volume":"154","year":"2006","journal-title":"European Journal of Endocrinology"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/humupd\/dmr046","article-title":"Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","year":"2012","journal-title":"Human Reproduction Update"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2265.1990.tb00857.x","article-title":"Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases","volume":"32","year":"1990","journal-title":"Clinical Endocrinology"},{"key":"ref2581","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/cen.13307","article-title":"Acute exercise elicits differential expression of insulin resistance genes in the skeletal muscle of patients with polycystic ovary syndrome","volume":"86","year":"2017","journal-title":"Clinical Endocrinology"},{"key":"ref2551","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1249\/MSS.0b013e31829ba9a1","article-title":"Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness","volume":"45","year":"2013","journal-title":"Medicine and Science in Sports and Exercise"},{"key":"ref2111","first-page":"3941","article-title":"Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome","volume":"11","year":"2014","journal-title":"Molecular Medicine Reports"},{"key":"ref2731","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-10-0709","article-title":"Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome","volume":"164","year":"2011","journal-title":"European Journal of Endocrinology"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13679-014-0127-6","article-title":"Aspects of cardiometabolic risk in women with polycystic ovary syndrome","volume":"3","year":"2014","journal-title":"Current Obesity Reports"},{"key":"ref2261","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1161\/ATVBAHA.114.304136","article-title":"Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the coronary artery risk development in young adults women\u2019s study","volume":"34","year":"2014","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"ref2021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/joe.0.1740001","article-title":"Developmental origin of polycystic ovary syndrome \u2013 a hypothesis","volume":"174","year":"2002","journal-title":"Journal of Endocrinology"},{"key":"ref1501","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11892-006-0056-1","article-title":"Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up","volume":"6","year":"2006","journal-title":"Current Diabates Reports"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/1358863X16682107","article-title":"Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers","volume":"22","year":"2017","journal-title":"Vascular Medicine"},{"key":"ref2521","first-page":"28","article-title":"Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency","volume":"36","year":"2013","journal-title":"Journal of Endocrinological Investigation"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"ref1081","first-page":"119","article-title":"ADHD medication use following FDA risk warnings","volume":"15","year":"2012","journal-title":"Journal of Mental Health Policy and Economics"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/cen.13307","article-title":"Acute exercise elicits differential expression of insulin resistance genes in the skeletal muscle of patients with polycystic ovary syndrome","volume":"86","year":"2017","journal-title":"Clinical Endocrinology"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","year":"2015","journal-title":"Endocrine Reviews"},{"key":"ref1131","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2265.2012.04434.x","article-title":"Vitamin D in the aetiology and management of polycystic ovary syndrome","volume":"77","year":"2012","journal-title":"Clinical Endocrinology"},{"key":"ref2621","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","year":"2005","journal-title":"European Journal of Endocrinology"},{"key":"ref2191","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.ATV.20.11.2414","article-title":"Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women","volume":"20","year":"2000","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: the Rotterdam Study","volume":"103","year":"2018","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","year":"2013","journal-title":"Obesity Reviews"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref2471","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.2196\/jmir.5417","article-title":"\u2018Less than a wife\u2019: a study of polycystic ovary syndrome content in teen and women\u2019s digital magazines","volume":"18","year":"2016","journal-title":"Journal of Medical Internet Research"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3109\/09513590903015528","article-title":"Central-to-peripheral fat ratio, but not peripheral body fat, is related to insulin resistance and androgen markers in polycystic ovary syndrome","volume":"25","year":"2009","journal-title":"Gynecological Endocrinology"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"e2953","DOI":"10.1371\/journal.pone.0002953","article-title":"The CAPN10 gene is associated with insulin resistance phenotypes in the spanish population","volume":"3","year":"2008","journal-title":"PLoS ONE"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/7\/7\/EC-18-0129.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/7\/7\/EC-18-0129.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:42:52Z","timestamp":1784554972000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/7\/7\/R238-R251\/336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":272,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1530\/ec-18-0129","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}